J van der Weide - JoVE Visualize

Showing results (11-20 of 23) with videos related to

Pageof 3

Sort By:

European Journal of Pharmacology|June 17, 1986

Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734J Van der Weide, J B De Vries, P G Tepper, et al.

European Journal of Pharmacology|February 10, 1987

In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranesJ Van der Weide, J B De Vries, P G Tepper, et al.

Tijdschrift Voor Gerontologie En Geriatrie|April 1, 1996

[Apolipoprotein E polymorphism and Alzheimer disease]J van der Weide, L S Steijns, J L Teepen, et al.

Pharmaceutisch Weekblad. Scientific Edition|October 25, 1985

Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonistA S Horn, P Tepper, J Van der Weide, et al.

Journal of Medicinal Chemistry|November 1, 1988

Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activationD Dijkstra, T B Mulder, H Rollema, et al.

The Journal of Urology|September 8, 2001

Lower urinary tract symptoms after renal transplantationM J van der Weide, L B Hilbrands, B L Bemelmans, et al.

Acta Neuropsychiatrica|March 18, 2016

D3 dopamine receptor mRNA expression in lymphocytes: a peripheral marker for schizophrenia?J van der Weide, L S W Steijns, M A M van der Geld, et al.

Clinical Chemistry|May 1, 1992

Nonisotopic binding assay for measuring vitamin B12 and folate in serumJ van der Weide, H C Homan, E Cozijnsen-van Rheenen, et al.

European Journal of Pharmacology|March 1, 1988

N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo modelsJ Van der Weide, J B De Vries, P G Tepper, et al.

European Journal of Pharmacology|February 9, 1988

The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptorsJ Van der Weide, M E Tendijck, P G Tepper, et al.

Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:

Pageof 3

European Journal of Pharmacology|June 17, 1986

Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734J Van der Weide, J B De Vries, P G Tepper, et al.

European Journal of Pharmacology|February 10, 1987

In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranesJ Van der Weide, J B De Vries, P G Tepper, et al.

Tijdschrift Voor Gerontologie En Geriatrie|April 1, 1996

[Apolipoprotein E polymorphism and Alzheimer disease]J van der Weide, L S Steijns, J L Teepen, et al.

Pharmaceutisch Weekblad. Scientific Edition|October 25, 1985

Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonistA S Horn, P Tepper, J Van der Weide, et al.

Journal of Medicinal Chemistry|November 1, 1988

Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activationD Dijkstra, T B Mulder, H Rollema, et al.

The Journal of Urology|September 8, 2001

Lower urinary tract symptoms after renal transplantationM J van der Weide, L B Hilbrands, B L Bemelmans, et al.

Acta Neuropsychiatrica|March 18, 2016

D3 dopamine receptor mRNA expression in lymphocytes: a peripheral marker for schizophrenia?J van der Weide, L S W Steijns, M A M van der Geld, et al.

Clinical Chemistry|May 1, 1992

Nonisotopic binding assay for measuring vitamin B12 and folate in serumJ van der Weide, H C Homan, E Cozijnsen-van Rheenen, et al.

European Journal of Pharmacology|March 1, 1988

N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo modelsJ Van der Weide, J B De Vries, P G Tepper, et al.

European Journal of Pharmacology|February 9, 1988

The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptorsJ Van der Weide, M E Tendijck, P G Tepper, et al.

Pageof 3